Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Agulnik

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Drug Design, Development and Therapy|March 26, 2016
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesRicardo Costa, Benedito A Carneiro, Sunandana Chandra, et al.
American Journal of Clinical Oncology|October 19, 2013
Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell CarcinomaTamer Refaat, Mehee Choi, Tarita O Thomas, et al.
Journal of Surgical Oncology|June 10, 2014
Examination of national lymph node evaluation practices for adult extremity soft tissue sarcomaKaren L Sherman, Christine V Kinnier, Domenico A Farina, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
Surgical Management of Retroperitoneal SarcomaDana A Dominguez, Sagus Sampath, Mark Agulnik, et al.
Investigational New Drugs|April 28, 2012
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcomaChristopher W Ryan, Chacon Matias, Mark Agulnik, et al.
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
JCO Oncology Practice|October 4, 2023
State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority CommunitiesCharles S Kamen, Don S Dizon, Chunkit Fung, et al.
Journal of Surgical Oncology|December 31, 2013
Assessment of multimodality therapy use for extremity sarcoma in the United StatesKaren L Sherman, Jeffrey D Wayne, Jeanette Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaChristine Elser, Lillian L Siu, Eric Winquist, et al.
Cancer Medicine|March 28, 2022
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancyDevon Miller, John A Livingston, Yeonhee Park, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Drug Design, Development and Therapy|March 26, 2016
Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectivesRicardo Costa, Benedito A Carneiro, Sunandana Chandra, et al.
American Journal of Clinical Oncology|October 19, 2013
Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell CarcinomaTamer Refaat, Mehee Choi, Tarita O Thomas, et al.
Journal of Surgical Oncology|June 10, 2014
Examination of national lymph node evaluation practices for adult extremity soft tissue sarcomaKaren L Sherman, Christine V Kinnier, Domenico A Farina, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
Surgical Management of Retroperitoneal SarcomaDana A Dominguez, Sagus Sampath, Mark Agulnik, et al.
Investigational New Drugs|April 28, 2012
A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcomaChristopher W Ryan, Chacon Matias, Mark Agulnik, et al.
Cancer|August 8, 2008
Evaluating the supportive care costs of severe radiochemotherapy-induced mucositis and pharyngitis : results from a Northwestern University Costs of Cancer Program pilot study with head and neck and nonsmall cell lung cancer patients who received care at a county hospital, a Veterans Administration hospital, or a comprehensive cancer care centerNarissa J Nonzee, Neal A Dandade, Urjeet Patel, et al.
JCO Oncology Practice|October 4, 2023
State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority CommunitiesCharles S Kamen, Don S Dizon, Chunkit Fung, et al.
Journal of Surgical Oncology|December 31, 2013
Assessment of multimodality therapy use for extremity sarcoma in the United StatesKaren L Sherman, Jeffrey D Wayne, Jeanette Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaChristine Elser, Lillian L Siu, Eric Winquist, et al.
Cancer Medicine|March 28, 2022
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancyDevon Miller, John A Livingston, Yeonhee Park, et al.
Pageof 12